» Articles » PMID: 19414596

The Nek6 and Nek7 Protein Kinases Are Required for Robust Mitotic Spindle Formation and Cytokinesis

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2009 May 6
PMID 19414596
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

Nek6 and Nek7 are members of the NIMA-related serine/threonine kinase family. Previous work showed that they contribute to mitotic progression downstream of another NIMA-related kinase, Nek9, although the roles of these different kinases remain to be defined. Here, we carried out a comprehensive analysis of the regulation and function of Nek6 and Nek7 in human cells. By generating specific antibodies, we show that both Nek6 and Nek7 are activated in mitosis and that interfering with their activity by either depletion or expression of reduced-activity mutants leads to mitotic arrest and apoptosis. Interestingly, while completely inactive mutants and small interfering RNA-mediated depletion delay cells at metaphase with fragile mitotic spindles, hypomorphic mutants or RNA interference treatment combined with a spindle assembly checkpoint inhibitor delays cells at cytokinesis. Importantly, depletion of either Nek6 or Nek7 leads to defective mitotic progression, indicating that although highly similar, they are not redundant. Indeed, while both kinases localize to spindle poles, only Nek6 obviously localizes to spindle microtubules in metaphase and anaphase and to the midbody during cytokinesis. Together, these data lead us to propose that Nek6 and Nek7 play independent roles not only in robust mitotic spindle formation but also potentially in cytokinesis.

Citing Articles

Phosphorylation on serine 72 modulates Rab7A palmitoylation and retromer recruitment.

Modica G, Tejeda-Valencia L, Sauvageau E, Yasa S, Maes J, Skorobogata O J Cell Sci. 2024; 138(1).

PMID: 39584231 PMC: 11828465. DOI: 10.1242/jcs.262177.


The kinase NEK6 positively regulates LSD1 activity and accumulation in local chromatin sub-compartments.

Knodel F, Eirich J, Pinter S, Eisler S, Finkemeier I, Rathert P Commun Biol. 2024; 7(1):1483.

PMID: 39523439 PMC: 11551153. DOI: 10.1038/s42003-024-07199-x.


Centrosomes and associated proteins in pathogenesis and treatment of breast cancer.

Athwal H, Kochiyanil A, Bhat V, Allan A, Parsyan A Front Oncol. 2024; 14:1370565.

PMID: 38606093 PMC: 11007099. DOI: 10.3389/fonc.2024.1370565.


A novel NLRP3 inhibitor as a therapeutic agent against monosodium urate-induced gout.

Park K, Shin I, Kim Y, Kang H, Oh S, Jang E Front Immunol. 2024; 14:1307739.

PMID: 38371945 PMC: 10869544. DOI: 10.3389/fimmu.2023.1307739.


The dynamic role of nucleoprotein SHCBP1 in the cancer cell cycle and its potential as a synergistic target for DNA-damaging agents in cancer therapy.

Zhou M, Duan L, Chen J, Li Y, Yin Z, Song S Cell Commun Signal. 2024; 22(1):131.

PMID: 38365687 PMC: 10874017. DOI: 10.1186/s12964-024-01513-0.


References
1.
Wu L, Osmani S, Mirabito P . A role for NIMA in the nuclear localization of cyclin B in Aspergillus nidulans. J Cell Biol. 1998; 141(7):1575-87. PMC: 2133011. DOI: 10.1083/jcb.141.7.1575. View

2.
Takeno A, Takemasa I, Doki Y, Yamasaki M, Miyata H, Takiguchi S . Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis. Br J Cancer. 2008; 99(8):1307-15. PMC: 2570518. DOI: 10.1038/sj.bjc.6604682. View

3.
Quarmby L, Mahjoub M . Caught Nek-ing: cilia and centrioles. J Cell Sci. 2005; 118(Pt 22):5161-9. DOI: 10.1242/jcs.02681. View

4.
OConnell M, Krien M, Hunter T . Never say never. The NIMA-related protein kinases in mitotic control. Trends Cell Biol. 2003; 13(5):221-8. DOI: 10.1016/s0962-8924(03)00056-4. View

5.
Holland P, Milne A, Garka K, Johnson R, Willis C, Sims J . Purification, cloning, and characterization of Nek8, a novel NIMA-related kinase, and its candidate substrate Bicd2. J Biol Chem. 2002; 277(18):16229-40. DOI: 10.1074/jbc.M108662200. View